Thoracolumbar Spine Devices Market Size & Share, by Product Type (Fusion Devices, Non-fusion Devices, Stimulation Devices); Disease Indication; End user - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

North America Market Analysis

In thoracolumbar spine devices market, North America region is predicted to capture over 48.5% revenue share by 2037. Developed countries such as the U.S. and Canada are proactively investing in the improvement of medical service delivery, creating a good distribution channel for this sector. In addition, the adaptive nature of this region for advanced surgical techniques and tools is creating a surge for innovative biologics and medical devices. For instance, in December 2023, ZimVie Inc. received FDA approval for its Vital Spinal Fixation System for use with Brainlab Spine & Trauma Navigation. This combined solution is designed to help surgeons achieve more accuracy and less radiation exposure during spinal surgeries.  

The thoracolumbar spine devices market in the U.S. is augmenting regional growth with its well-established healthcare infrastructure. This country is also fostering a lucrative business atmosphere due to its aging population, who have higher possibilities of undergoing spinal surgeries. Thus, more domestic medical suppliers are being globally recognized for their contribution to this sector. For instance, in July 2024, MiRus received Breakthrough Device Designation for its EUROPA Posterior Cervical System from the FDA due to the use of proprietary rhenium alloys in production. This system gained popularity for its efficacy in treating the cervical and upper thoracic spine.

Canada is magnifying its participation in the thoracolumbar spine devices market by making remarkable investments in associated research and development. The country’s desperate efforts to improve patient and surgical outcomes through funding the infrastructure is acting as a financial cushion for this sector. For instance, in February 2022, a project in Canada, called Mend the Gap: A Transformative Biomaterials Platform for Spinal Cord Repair project received a grant of USD 24 million over six-year. They were awarded through the New Frontiers in Research Fund (NFRF) 2020 Transformation stream for developing a new minimally invasive surgical treatment for SCI. Such innovations are further evolving this sector, offering better results.

APAC Market Statistics

Asia Pacific is poised to register a significant growth rate in the thoracolumbar spine devices market by 2037. Unhealthy changes in lifestyle due to rapid urbanization in developing countries such as Japan, China, Australia, and India led to spinal disorders. This is further driving demand for surgical expertise and equipment, subsequently expanding the consumer base for this sector. The forecasted demographics of the aging population in this region also indicate the rise in SCI patient volume, expanding this sector. Moreover, the collaborative efforts of government bodies and healthcare professionals have increased the frequency of spine surgeries in this region, inflating demand in this sector.

India is reviving its position in the thoracolumbar spine devices market by issuing supportive initiatives and reimbursement policies. The country is leveraging its own production to become a good supplier of such medical devices with promotional campaigns such as Made in India. For instance, in 2020, the government of India launched a Production Linked Incentive (PLI) Scheme with a financial outlay of USD 395.9 million for FY 2022-2023 to FY 2026-27. This also offers support manufacturers with a 5% incentive on sales increment of medical devices produced in India.

China, with its manufacturing capabilities and strategic foreign relationships, is positioned at the forefront of the regional thoracolumbar spine devices market. The country is also focused on creating a good marketplace for international participants in the medical device industry, including thoracic systems. According to the International Trade Administration report, published in April 2023, the industry size of medical devices in China is estimated to reach USD 48.8 billion by 2026, exhibiting a CAGR of 8.3%. Another 2019 report estimated the worth of domestic production to be USD 59.0 billion.